Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04033575 · ClinicalTrials.gov registry record · Phase 4
Clinical Investigation of a Toothpaste Containing Stannous Fluoride as Compared to Colgate Fluoride Toothpaste
A Phase 4 study of Gingivitis, sponsored by Colgate Palmolive.
- Completed
- Registry status
- Phase 4
- Development phase
- 88
- Enrollment target
- 1
- Study location
NCT04033575: Completed Phase 4 study of Gingivitis, sponsored by Colgate Palmolive.
NCT04033575 is a Phase 4 study of Gingivitis that has completed, run by Colgate Palmolive. The registered enrollment target is 88 participants, below the 233-participant average among 25 other Gingivitis trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04033575, a Phase 4 study of Gingivitis, has completed, sponsored by Colgate Palmolive.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 88 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to evaluate the clinical efficacy of a toothpaste containing stannous fluoride as compared to Colgate Fluoride Toothpaste in reducing plaque and gingivitis - a three- month study.
Primary Outcome
Gingivitis scale (Loe \& Silness Gingival Index) Units on a scale 0 to 3 (0 = no inflammation, 1 = Mild inflammation-slight change in color and little change in texture 2 = Moderate inflammation-moderate glazing, redness, edema and hypertrophy. Tendency to bleed upon probing. 3 = Severe inflammation-marked redness and hypertrophy. Tendency to spontaneous bleeding)
Conditions Studied
Interventions
- DRUG Colgate Total SF
- DRUG Colgate Cavity Protection toothpaste
Study Locations (1)
Florida
- Consumer Research Consulting, LLC - Melbourne
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2019-03-06 |
| Est. Completion | 2019-07-01 |
| Phase | Phase 4 |
What the finished NCT04033575 record still lists
NCT04033575 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 88 participants, a relatively small participant target, below the 233-participant average among 25 other Gingivitis trials with a reported enrollment target (62% lower).
The record links to 1 condition, with Gingivitis appearing as the primary indexed condition, and to 2 interventions - of which Colgate Total SF is the first listed.
NCT04033575 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT04033575 about?
NCT04033575 is a clinical study titled "Clinical Investigation of a Toothpaste Containing Stannous Fluoride as Compared to Colgate Fluoride Toothpaste". The objective of this study is to evaluate the clinical efficacy of a toothpaste containing stannous fluoride as compared to Colgate Fluoride Toothpaste in reducing plaque and gingivitis - a three- month study.
What is the current status of trial NCT04033575?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 88 participants. The study started on 2019-03-06. Estimated completion is 2019-07-01.
What conditions does trial NCT04033575 study?
This clinical trial studies the following conditions: Gingivitis.
What interventions are being tested in trial NCT04033575?
The interventions under investigation include: Colgate Total SF (DRUG), Colgate Cavity Protection toothpaste (DRUG).
Who is sponsoring clinical trial NCT04033575?
This trial is sponsored by Colgate Palmolive, which has 51 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04033575 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gingivitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04033575's enrollment target sits among peer trials
88 15th of 25 higher than 11 of 25 other Gingivitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gingivitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Assessing Gingivitis and Plaque From a Marketed Toothpaste
ACTIVE NOT RECRUITING · Phase 4
-
A Study is to Evaluate a Regimen on Gingivitis Using Traditional and Novel Assessment Methods
COMPLETED · Phase 4
-
Imaging-based Assessment of Oral Biofilm and Gingival Health
RECRUITING · NA
-
Extending Dental Care to Nursing Home Residents to Reduce Mouth Infections and Incidence of Pneumonia and Improve Diabetic Glucose Control
RECRUITING · NA
-
A Clinical Study to Evaluate the Effectiveness of an Experimental Toothpaste in Improving Gum Health and Reducing Plaque Accumulation
RECRUITING · NA
-
Effectiveness of Dual Light Electric Toothbrush vs. Manual Toothbrush in Orthodontic Patients Undergoing Oral Surgery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04536103 · 88 participants
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI